About 4 Trademarks found for “XUDA*”

Pharmaceutical preparations for human use, namely preparations for the treatment of inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue, immunological diseases and disorders namely auto-immune diseases, oncological diseases and disorders and antivirals.

Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract, namely, for the treatment of obesity, for the treatment of dental and oral diseases, for use in gastroenterology, antiflatulants, burn relief medication, calcium channel blockers, diarrhea medication and gastrointestinal medication; pharmaceutical preparations for the treatment of diseases and disorders relating to metabolism, namely, for the treatment of diabetes, for the treatment of hypertension, for the treatment of stroke, for the treatment of osteoporosis, cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations for the treatment of diseases and disorders of blood and blood forming organs, namely anticoagulants and anticonvulsants; but excluding pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders, cancer and viral infections.

Pharmaceutical preparations for human use, namely preparations for the treatment of immunological diseases and disorders namely, auto-immune diseases, immunologic deficiency syndromes, autoimmune connective tissue diseases, inflammatory diseases and disorders, namely inflammatory connective tissue diseases, endocrinological diseases and disorders, namely growth disorders, oncological diseases and disorders, neurological diseases and disorders, namely preparations for use in treating multiple sclerosis, parkinsons, infertility diseases and disorders, metabolic diseases and disorders, namely, phenylketonuria (pku), growth disorders, rheumatological diseases and disorders.

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central and peripheral nervous system, namely, Parkinson's disease, Huntington's disease, Gilles de la Tourette's syndrome, depression, anxiety, cognitive disturbance, restless legs syndrome, myoclonus, tic disorders, movement disorders, levodopa-induced dyskinesia in Parkinson's disease, and tardive dyskinesia induced by neuroleptics.